Concepedia

Robert McEwen

RM

Statistics

Publications

32

Citations

4.2K

H-Index

26

Active since

1997

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

University of Birmingham

Vall d'Hebron Institute of Oncology

Vall d'Hebron Hospital Universitari

Robert McEwen is an author at AstraZeneca (United Kingdom) specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

1997–2023

32

Publications

32

VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

Zhongwu Lai, Aleksandra Markovets, Miika Ahdesmäki et al. · Nucleic Acids Research · 2016 · 1K citations · Full text

, , +20

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 373 citations · Full text

Svp1p defines a family of phosphatidylinositol 3,5‐bisphosphate effectors

Stephen K. Dove, Robert C. Piper, Robert McEwen et al. · The EMBO Journal · 2004 · 362 citations · Full text

AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations

David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue et al. · Journal of Clinical Oncology · 2017 · 315 citations · Full text

The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiae

Frank T. Cooke, Stephen K. Dove, Robert McEwen et al. · Current Biology · 1998 · 224 citations · Full text

, , +12

1–5 of 32